Unknown

Dataset Information

0

1,3-Bis(2-thienylmeth-yl)-4,5-dihydro-imidazolium trichlorido(?-p-cymene)ruthenate(II).

ABSTRACT: The asymmetric unit of the title compound, (C(13)H(15)N(2)S(2))[RuCl(3)(C(10)H(14))], contains a 1,3-(2-thienylmeth-yl)-4,5-dihydro-imidazolium cation and a trichlorido(?(6)-p-cymene)ruthenate(II) anion. The thio-phene rings of the cation are disordered by an 180° rotation about the thio-phene-CH(2) bonds with occupancies of 0.847?(5)/0.153?(5) and 0.700?(5)/0.300?(5), respectively. The Ru atom exhibits a distorted octa-hedral coordination with the benzene ring of the p-cymene ligand formally occupying three sites and three Cl atoms occupying the other three sites. The short C-N bond lengths in the imidazoline ring indicate partial electron delocalization within the N-C-N fragment. Cation and anions are connected through five inter-molecular C-H?Cl hydrogen bonds and one C-H?? hydrogen bond, forming a three-dimensional hydrogen-bonded network.

SUBMITTER: Arslan H 

PROVIDER: S-EPMC2968218 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

1,3-Bis(2-thienylmeth-yl)-4,5-dihydro-imidazolium trichlorido(η-p-cymene)ruthenate(II).

Arslan Hakan H   Vanderveer Don D   Ozdemir Ismail I   Gürbüz Nevin N   Gök Yetkin Y   Cetinkaya Bekir B  

Acta crystallographica. Section E, Structure reports online 20090110 Pt 2

The asymmetric unit of the title compound, (C(13)H(15)N(2)S(2))[RuCl(3)(C(10)H(14))], contains a 1,3-(2-thienylmeth-yl)-4,5-dihydro-imidazolium cation and a trichlorido(η(6)-p-cymene)ruthenate(II) anion. The thio-phene rings of the cation are disordered by an 180° rotation about the thio-phene-CH(2) bonds with occupancies of 0.847 (5)/0.153 (5) and 0.700 (5)/0.300 (5), respectively. The Ru atom exhibits a distorted octa-hedral coordination with the benzene ring of the p-cymene ligand formally oc  ...[more]

Similar Datasets

Unknown 1,3-Bis(thio-phen-2-ylmeth-yl)-3,4,5,6-tetra-hydro-pyrimidinium trichlorido(?-p-cymene)ruthenate(II).
| S-EPMC2968014 | biostudies-literature
Unknown Tetra-ethyl-ammonium trichlorido(η-p-cymene)ruthenate(II).
| S-EPMC2971931 | biostudies-literature
Unknown 1,3-Bis(4-tert-butyl-benz-yl)-4,5-dihydro-imidazolium chloride monohydrate.
| S-EPMC2968238 | biostudies-literature
Unknown (?-p-Cymene)bis-(trichlorido-stannyl)(triethoxy-phosphine-?P)ruthenium(II).
| S-EPMC2971135 | biostudies-literature
Unknown catena-Poly[[bis-(nitrato-?O)copper(II)]-?-1,4-bis-(4,5-dihydro-1,3-oxazol-2-yl)-benzene-?N:N'].
| S-EPMC3152049 | biostudies-literature
Unknown (?(6)-p-Cymene)(1,3-dimesityl-2,3-dihydro-1H-imidazol-2-yl-idene)bis-(pentafluorobenzoato-?O)ruthenium(II) dichloro-methane disolvate.
| S-EPMC3588321 | biostudies-literature
Unknown 2,6-Bis[(S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine.
| S-EPMC3089107 | biostudies-literature
Unknown 1,3-Bis(2,6-diisopropyl-phen-yl)-4,5-dihydro-1H-imidazol-3-ium triiodide.
| S-EPMC3011707 | biostudies-literature
Unknown [2,6-Bis(4,5-dihydro-1H-imidazol-2-yl)pyridine]dichloridomanganese(II).
| S-EPMC2977615 | biostudies-literature
Unknown {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis-(N,N-di-methyl-formamide)copper(II) bis-(hexa-fluoridoantimonate).
| S-EPMC2969361 | biostudies-literature